Ngā hua rapu kaituhi

1

Prevention of post-discharge venous thromboembolism in patients with rheumatoid arthritis undergoing knee or hip arthroplasty: a continuing matter of debate mā NURMOHAMED, M, DIJKMANS, B

I whakaputaina 2001

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
2

Risk of post-discharge venous thromboembolism in patients with rheumatoid arthritis undergoing knee or hip arthroplasty. Is prolonged thromboprophylaxis warranted or dangerous? mā NURMOHAMED, M, LEMS, W, DIJKMANS, B

I whakaputaina 1999

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
3

Adverse events in patients with rheumatoid arthritis treated with infliximab in daily clinical practice mā Neven, N, Vis, M, Voskuyl, A, Wolbink, G, Nurmohamed, M, Dijkmans, B, Lems, W

I whakaputaina 2005

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
4

Neutrophil activation identifies patients with active polyarticular gout mā Vedder, D., Gerritsen, M., Duvvuri, B., van Vollenhoven, R. F., Nurmohamed, M. T., Lood, C.

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
5

The RAPID3 questionnaire as a screening tool to reduce the number of outpatient clinic visits: a retrospective cohort study mā Wiegel, J., Seppen, B. F., ter Wee, M. M., Nurmohamed, M. T., Boers, M., Bos, W. H.

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
6

The pharmacokinetics and pharmacodynamics of dermatan sulphate MF701 during haemodialysis for chronic renal failure. mā Gianese, F, Nurmohamed, M T, Imbimbo, B P, Büller, H R, Berckmans, R J, Ten Cate, J W

I whakaputaina 1993

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
7

Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis mā Wolbink, G, Voskuyl, A, Lems, W, de Groot, E, Nurmohamed, M, Tak, P, Dijkmans, B, Aarden, L

I whakaputaina 2005

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
8

High levels of human anti‐human antibodies to adalimumab in a patient not responding to adalimumab treatment mā Bartelds, G M, Wolbink, G J, Stapel, S, Aarden, L, Lems, W F, Dijkmans, B A C, Nurmohamed, M T

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
9

Antibodies against human 60 kDa heat shock protein are not associated with cardiovascular disease in patients with rheumatoid arthritis mā van Halm, V P, Slot, M C, Nurmohamed, M T, Tervaert, J W Cohen, Dijkmans, B A C, Voskuyl, A E

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
10

Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis mā Boers, M, Nurmohamed, M, Doelman, C, Lard, L, Verhoeven, A, Voskuyl, A, Huizinga, T, van de Stadt, R J, Dijkmans, B, van der Linden, S.

I whakaputaina 2003

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
11

Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study mā van den Hoek, J., Boshuizen, H. C., Roorda, L. D., Tijhuis, G. J., Nurmohamed, M. T., van den Bos, G. A. M., Dekker, J.

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
12

Aortic root diameter is associated with HLA-B27: identifying the patient with ankylosing spondylitis at risk for aortic valve regurgitation mā Baniaamam, M., Heslinga, S. C., Konings, T. C., Handoko, M. L., Kamp, O., van Halm, V. P., van der Horst-Bruinsma, I. E., Nurmohamed, M. T.

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
13

Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis mā van Denderen, J C, van der Paardt, M, Nurmohamed, M, de Ryck, Y M M A, Dijkmans, B, van der Horst-Bru..., I E

I whakaputaina 2005

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
14

Statin therapy might be beneficial for patients with ankylosing spondylitis mā van Denderen, J C, Peters, M J L, van Halm, V P, van der Horst‐Bruinsma, I E, Dijkmans, B A C, Nurmohamed, M T

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
15

Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis mā Klaasen, R., Herenius, M M J, Wijbrandts, C A, de Jager, W, van Tuyl, L H, Nurmohamed, M T, Prakken, B J, Gerlag, D M, Tak, P P

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
16

Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-up mā Vogelzang, E. H., Hebing, R. C. F., Nurmohamed, M. T., van Kuijk, A. W. R., Kruijff, J. W. F., l’Ami, M. J., Krieckaert, C. L. M., Wolbink, G.

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
17

Implicit and explicit attitudes towards disease-modifying antirheumatic drugs as possible target for improving medication adherence mā van Heuckelum, M., Linn, A. J., Vandeberg, L., Hebing, R. C. F., van Dijk, L., Vervloet, M., Flendrie, M., Nurmohamed, M. T., van Dulmen, S., van den Bemt, B. J. F., van den Ende, C. H. M.

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
18

The effect of anti-TNF treatment on body composition and insulin resistance in patients with rheumatoid arthritis mā van den Oever, I. A. M., Baniaamam, M., Simsek, S., Raterman, H. G., van Denderen, J. C., van Eijk, I. C., Peters, M. J. L., van der Horst-Bruinsma, I. E., Smulders, Y. M., Nurmohamed, M. T.

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
19

Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid a... mā Lucassen, M. J. J., ter Wee, M. M., den Uyl, D., Konijn, N. P. C., Nurmohamed, M. T., Voskuyl, A. E., van Schaardenburg, D., Kerstens, P. J. S. M., Bultink, I. E. M., Boers, M., Lems, W. F.

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
20

Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis mā Peters, M J L, Vis, M, van Halm, V P, Wolbink, G J, Voskuyl, A E, Lems, W F, Dijkmans, B A C, Twisk, J W R, de Koning, M H M T, van de Stadt, R J, Nurmohamed, M T

I whakaputaina 2007

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Nurmohamed, M T

Prevention of post-discharge venous thromboembolism in patients with rheumatoid arthritis undergoing knee or hip arthroplasty: a continuing matter of debate mā NURMOHAMED, M, DIJKMANS, B

Risk of post-discharge venous thromboembolism in patients with rheumatoid arthritis undergoing knee or hip arthroplasty. Is prolonged thromboprophylaxis warranted or dangerous? mā NURMOHAMED, M, LEMS, W, DIJKMANS, B

Adverse events in patients with rheumatoid arthritis treated with infliximab in daily clinical practice mā Neven, N, Vis, M, Voskuyl, A, Wolbink, G, Nurmohamed, M, Dijkmans, B, Lems, W

Neutrophil activation identifies patients with active polyarticular gout mā Vedder, D., Gerritsen, M., Duvvuri, B., van Vollenhoven, R. F., Nurmohamed, M. T., Lood, C.

The RAPID3 questionnaire as a screening tool to reduce the number of outpatient clinic visits: a retrospective cohort study mā Wiegel, J., Seppen, B. F., ter Wee, M. M., Nurmohamed, M. T., Boers, M., Bos, W. H.

The pharmacokinetics and pharmacodynamics of dermatan sulphate MF701 during haemodialysis for chronic renal failure. mā Gianese, F, Nurmohamed, M T, Imbimbo, B P, Büller, H R, Berckmans, R J, Ten Cate, J W

Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis mā Wolbink, G, Voskuyl, A, Lems, W, de Groot, E, Nurmohamed, M, Tak, P, Dijkmans, B, Aarden, L

High levels of human anti‐human antibodies to adalimumab in a patient not responding to adalimumab treatment mā Bartelds, G M, Wolbink, G J, Stapel, S, Aarden, L, Lems, W F, Dijkmans, B A C, Nurmohamed, M T

Antibodies against human 60 kDa heat shock protein are not associated with cardiovascular disease in patients with rheumatoid arthritis mā van Halm, V P, Slot, M C, Nurmohamed, M T, Tervaert, J W Cohen, Dijkmans, B A C, Voskuyl, A E

Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis mā Boers, M, Nurmohamed, M, Doelman, C, Lard, L, Verhoeven, A, Voskuyl, A, Huizinga, T, van de Stadt, R J, Dijkmans, B, van der Linden, S.

Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study mā van den Hoek, J., Boshuizen, H. C., Roorda, L. D., Tijhuis, G. J., Nurmohamed, M. T., van den Bos, G. A. M., Dekker, J.

Aortic root diameter is associated with HLA-B27: identifying the patient with ankylosing spondylitis at risk for aortic valve regurgitation mā Baniaamam, M., Heslinga, S. C., Konings, T. C., Handoko, M. L., Kamp, O., van Halm, V. P., van der Horst-Bruinsma, I. E., Nurmohamed, M. T.

Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis mā van Denderen, J C, van der Paardt, M, Nurmohamed, M, de Ryck, Y M M A, Dijkmans, B, van der Horst-Bru..., I E

Statin therapy might be beneficial for patients with ankylosing spondylitis mā van Denderen, J C, Peters, M J L, van Halm, V P, van der Horst‐Bruinsma, I E, Dijkmans, B A C, Nurmohamed, M T

Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis mā Klaasen, R., Herenius, M M J, Wijbrandts, C A, de Jager, W, van Tuyl, L H, Nurmohamed, M T, Prakken, B J, Gerlag, D M, Tak, P P

Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-up mā Vogelzang, E. H., Hebing, R. C. F., Nurmohamed, M. T., van Kuijk, A. W. R., Kruijff, J. W. F., l’Ami, M. J., Krieckaert, C. L. M., Wolbink, G.

Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis mā Peters, M J L, Vis, M, van Halm, V P, Wolbink, G J, Voskuyl, A E, Lems, W F, Dijkmans, B A C, Twisk, J W R, de Koning, M H M T, van de Stadt, R J, Nurmohamed, M T

Ngā utauta rapu: